These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29952440)

  • 1. Kawasaki Disease - A Review of Treatment and Outcomes in an Irish Paediatric Cohort 2010-14.
    Flinn AM; Gavin PJ; McMahon CJ; Oslizok P; Butler KM
    Ir Med J; 2018 Feb; 111(2):691. PubMed ID: 29952440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
    Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of Kawasaki disease.
    Weng KP; Ou SF; Lin CC; Hsieh KS
    J Chin Med Assoc; 2011 Nov; 74(11):481-4. PubMed ID: 22100015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
    Chen S; Dong Y; Kiuchi MG; Wang J; Li R; Ling Z; Zhou T; Wang Z; Martinek M; Pürerfellner H; Liu S; Krucoff MW
    JAMA Pediatr; 2016 Dec; 170(12):1156-1163. PubMed ID: 27749951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease in infants less than one year of age: an Italian cohort from a single center.
    Mastrangelo G; Cimaz R; Calabri GB; Simonini G; Lasagni D; Resti M; Trapani S
    BMC Pediatr; 2019 Sep; 19(1):321. PubMed ID: 31493782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of acute and refractory Kawasaki disease.
    Tacke CE; Burgner D; Kuipers IM; Kuijpers TW
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1203-15. PubMed ID: 23199405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D; Wong M; Isaacs D
    J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
    Dhanrajani A; Yeung RSM
    Curr Opin Rheumatol; 2017 Sep; 29(5):547-552. PubMed ID: 28661936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Kawasaki disease.
    Eleftheriou D; Levin M; Shingadia D; Tulloh R; Klein NJ; Brogan PA
    Arch Dis Child; 2014 Jan; 99(1):74-83. PubMed ID: 24162006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F; Bostan OM; Celebi S; Uysal B; Hamitoglu S; Cil E
    Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG; Gauvreau K; Baker A; Son MB; Sundel R; Dionne A; Giorgio T; De Ferranti S; Newburger JW
    Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.